NT
Nikhil Teja Reddy Mandha
About Nikhil Teja Reddy Mandha
Data last updated:
Nikhil Teja Reddy Mandha is a Director at Enal Drugs Pvt Ltd (since 2024), Director at Apichem Laboratories Private Limited (since 2020) and Director at Zen Distillation Technologies Private Limited (since 2025), and holds 3 more current directorships. The companies operate in Pharma, Chemicals and Materials and Chemicals. The 5 current companies with reported revenue have a combined latest revenue of ₹118 Cr; the largest is Enal Drugs Pvt Ltd at ₹55.27 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Feb 2024 | 1990 | ₹55.27 Cr (FY 2024) | Active | |
| Director | 06 Jan 2020 | 2020 | ₹55.25 Cr (FY 2024) | Active | |
| Director | 10 Sep 2025 | 2010 | ₹7.42 Cr (FY 2025) | Active | |
| Director | 31 Dec 2019 | 2019 | ₹2 Lakh (FY 2024) | Active | |
| Director | 10 Sep 2025 | 2020 | ₹20,795 (FY 2025) | Active | |
| Director | 29 Apr 2025 | 2025 | Active |
Board colleagues of Nikhil Teja Reddy Mandha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Achyuth Reddy Manne | 08170401 | Enal Drugs Pvt Ltd , Apichem Laboratories Private Limited | Director |
| Suresh Babu Sunkaraneni | 00127565 | Enal Drugs Pvt Ltd | Managing Director |
| Uma Sunkaraneni | 00390992 | Enal Drugs Pvt Ltd | Director |
| Birendra Kumar Nath | Apichem Laboratories Private Limited | Company Secretary | |
| Pooja Reddy Konda Reddy | 09120053 | Zen Distillation Technologies Private Limited , Apiform Laboratories Private Limited and 2 more | Director |
| Sindhuja Reddy Manne | 02977495 | S V Pharma Analytical Services Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nikhil Teja Reddy Mandha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nikhil Teja Reddy Mandha
Nikhil Teja Reddy Mandha currently holds 6 directorships: Enal Drugs Pvt Ltd (Director, since 01 Feb 2024, revenue ₹55.27 Cr (FY 2024)); Apichem Laboratories Private Limited (Director, since 06 Jan 2020, revenue ₹55.25 Cr (FY 2024)); Zen Distillation Technologies Private Limited (Director, since 10 Sep 2025, revenue ₹7.42 Cr (FY 2025)); Apiform Laboratories Private Limited (Director, since 31 Dec 2019, revenue ₹2 Lakh (FY 2024)); Organozen Chemicals Private Limited (Director, since 10 Sep 2025, revenue ₹20,795 (FY 2025)); and 1 more.
Nikhil Teja Reddy Mandha was first appointed on 31 Dec 2019 as Director at Apiform Laboratories Private Limited. The most recent appointment on record is 10 Sep 2025 at Organozen Chemicals Private Limited.
The 5 current companies of Nikhil Teja Reddy Mandha that report revenue have a combined latest revenue of ₹118 Cr: Enal Drugs Pvt Ltd ₹55.27 Cr (FY 2024); Apichem Laboratories Private Limited ₹55.25 Cr (FY 2024); Zen Distillation Technologies Private Limited ₹7.42 Cr (FY 2025); Apiform Laboratories Private Limited ₹2 Lakh (FY 2024); Organozen Chemicals Private Limited ₹20,795 (FY 2025).
The current boards of Nikhil Teja Reddy Mandha's companies include Achyuth Reddy Manne (Enal Drugs Pvt Ltd), Suresh Babu Sunkaraneni (Enal Drugs Pvt Ltd), Uma Sunkaraneni (Enal Drugs Pvt Ltd), Birendra Kumar Nath (Apichem Laboratories Private Limited), Pooja Reddy Konda Reddy (Zen Distillation Technologies Private Limited), Sindhuja Reddy Manne (S V Pharma Analytical Services Private Limited).